Tevogen Bio Holdings Income Statement (2021-2026) | TVGN

Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 1.35M1.03M1.12M0.91M20.81M4.12M3.26M2.84M3.20M2.70M3.11M2.11M3.13M
Selling, General & Administrative (Quarter) 0.28M0.26M0.20M0.21M0.98M1.15M1.21M1.10M8.71M4.47M2.82M6.53M7.16M2.74M2.62M2.50M2.27M
Restructuring Costs (Quarter) 7.50M
Other Operating Expenses (Quarter) -7.50M
Operating Expenses (Quarter) 0.28M0.26M0.20M0.21M2.32M2.18M2.33M2.01M29.52M8.60M6.09M9.36M10.36M5.44M5.73M4.61M5.40M
Operating Income (Quarter) -2.32M-2.18M-2.33M-2.01M-29.52M-8.60M-6.09M-9.36M-10.36M-5.44M-5.73M-4.61M-5.40M
EBIT (Quarter) -2.32M-2.18M-2.33M-2.01M-29.52M-8.60M-6.09M-9.36M-10.36M-5.44M-5.73M-4.61M-5.40M
Non-operating items
Non Operating Investment Income (Quarter) 0.14M0.33M1.74M2.74M1.78M0.30M0.33M0.32M
Non Operating Income (Quarter) 0.26M0.47M1.81M2.83M1.73M0.33M0.33M-0.18M
Net income details
EBT (Quarter) -2.61M-2.18M-2.62M-2.33M-29.67M-8.60M-6.10M-9.38M-10.38M-5.44M-5.73M-4.61M-5.40M
Profit After Tax (Quarter) -0.03M0.21M1.61M2.61M-30.76M-22.18M-3.90M-3.63M11.26M-9.66M-5.88M-9.44M-10.37M-5.50M-5.73M-4.68M-5.45M
Income from Continuing Operations (Quarter) -2.61M-2.18M-2.62M-2.33M-29.67M-8.60M-6.10M-9.38M-10.38M-5.44M-5.73M-4.61M-5.40M
Consolidated Net Income (Quarter) -2.61M-2.18M-2.62M-2.33M-29.67M-8.60M-6.10M-9.38M-10.38M-5.44M-5.73M-4.61M-5.40M
Income towards Parent Company (Quarter) -2.61M-2.18M-2.62M-2.33M-29.67M-8.60M-6.10M-9.38M-10.38M-5.44M-5.73M-4.61M-5.40M
Net Income towards Common Stockholders (Quarter) -0.02M0.16M0.40M1.83M0.71M-0.15M-3.90M-3.63M10.51M-6.08M-5.91M-9.41M-10.50M-5.64M-5.86M-4.82M-5.62M
Additional items
EPS (Basic) (Quarter) 0.000.000.030.05-0.26-0.18-0.03-0.140.08-0.04-0.03-3.49-3.25-0.03-0.03-7.96-1.61
EPS (Weighted Average and Diluted) (Quarter) 0.000.010.030.05-0.26-0.18-0.03-0.14-0.26-0.04-0.03-3.49-3.25-0.03-0.03-7.96-1.61
Shares Outstanding (Weighted Average) (Quarter) 7.20M35.95M35.95M35.95M1.45M120.00M120.00M120.00M24.75M137.33M145.66M170.17M2.93M3.23M184.31M196.03M3.32M17.39M
Shares Outstanding (Diluted Average) (Quarter) 11.98M35.95M11.98M35.95M1.45M120.00M120.00M120.00M24.75M142.39M148.15M170.17M2.93M3.23M182.54M196.03M3.32M3.49M
EBITDA (Quarter) -2.32M-2.18M-2.33M-2.01M-29.52M-8.60M-6.09M-9.36M-10.36M-5.44M-5.73M-4.61M-5.40M
Interest Expenses (Quarter) 0.29M0.30M0.32M0.16M0.01M0.02M0.02M